Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

High Incidence of Secondary Sclerosing Cholangitis in Hospitalized "First-wave" COVID-19 Patients: a Retrospective Single Center Study

NCT05233553 is registered in ClinicalTrials.gov with University Hospital Tuebingen as lead sponsor.

NCT NCT05233553
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05233553 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
High Incidence of Secondary Sclerosing Cholangitis in Hospitalized "First-wave" COVID-19 Patients: a Retrospective Single Center Study
Lead sponsor
University Hospital Tuebingen
Phase
Observational
Overall status
Completed
Start date
March 1, 2020
Completion date
January 31, 2022
Enrollment
64 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

covid-19, secondary sclerosing cholangitis